Literature DB >> 19885086

Dirlotapide, a U.S. Food and Drug Administration-approved first-in-class obesity drug for dogs-will humans be next?

David C Klonoff.   

Abstract

Entities:  

Keywords:  MTP inhibitors; dirlotapide; dogs; obesity; selective microsomal triglyceride transfer protein inhibitors

Year:  2007        PMID： 19885086      PMCID： PMC2769592          DOI： 10.1177/193229680700100301

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  11 in total

1.  Performance-enhancing substances: what athletes are using.

Authors:  J A Krcik
Journal:  Cleve Clin J Med       Date:  2001-04       Impact factor: 2.321

Review 2.  MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?

Authors:  John R Burnett; Gerald F Watts
Journal:  Expert Opin Ther Targets       Date:  2007-02       Impact factor: 6.902

3.  Increasing trends in waist circumference and abdominal obesity among US adults.

Authors:  Chaoyang Li; Earl S Ford; Lisa C McGuire; Ali H Mokdad
Journal:  Obesity (Silver Spring)       Date:  2007-01       Impact factor: 5.002

Review 4.  Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

Authors:  Raj S Padwal; Sumit R Majumdar
Journal:  Lancet       Date:  2007-01-06       Impact factor: 79.321

5.  Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.

Authors:  Marina Cuchel; LeAnne T Bloedon; Philippe O Szapary; Daniel M Kolansky; Megan L Wolfe; Antoine Sarkis; John S Millar; Katsunori Ikewaki; Evan S Siegelman; Richard E Gregg; Daniel J Rader
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

6.  Prevalence of obesity in dogs examined by Australian veterinary practices and the risk factors involved.

Authors:  P D McGreevy; P C Thomson; C Pride; A Fawcett; T Grassi; B Jones
Journal:  Vet Rec       Date:  2005-05-28       Impact factor: 2.695

7.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

8.  CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.

Authors:  Charles E Chandler; Donald E Wilder; Judith L Pettini; Yvette E Savoy; Stephen F Petras; George Chang; John Vincent; H James Harwood
Journal:  J Lipid Res       Date:  2003-07-01       Impact factor: 5.922

Review 9.  Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease.

Authors:  D J Rader; H B Brewer
Journal:  JAMA       Date:  1993-08-18       Impact factor: 56.272

10.  Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States.

Authors:  E M Lund; P J Armstrong; C A Kirk; L M Kolar; J S Klausner
Journal:  J Am Vet Med Assoc       Date:  1999-05-01       Impact factor: 1.936
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.